Antigua and Barbuda vs Ecuador: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Ecuador
100.0%
in 2024
Antigua and Barbuda rank
1st
Ecuador rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Ecuador
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2010 it was Ecuador ahead.
Antigua and Barbuda ranks 1st and Ecuador ranks 1st of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 86.0% | 14.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Ecuador?
- Antigua and Barbuda, at 100.0% against 100.0% in Ecuador as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Ecuador?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Ecuador?
- 5 years are reported by both, from 2010 to 2022.
- How do Antigua and Barbuda and Ecuador rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Ecuador ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.